TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

被引：40

作者：

Zixin, Ye ^{[1
,2
,3
,4
]}

Lulu, Chen ^{[5
,6
]}

Xiangchang, Zeng ^{[1
,2
,3
,4
]}

Qing, Fang ^{[5
]}

Binjie, Zheng ^{[1
,2
,3
,4
]}

Chunyang, Luo ^{[6
]}

Tai, Rao ^{[1
,2
,3
,4
]}

Dongsheng, Ouyang ^{[1
,2
,3
,4
,5
]}

机构：

[1] Cent South Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Peoples R China

[2] Cent South Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha, Peoples R China

[3] Minist Educ, Engn Res Ctr Appl Technol Pharmacogen, Changsha, Peoples R China

[4] Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China

[5] Hunan Key Lab Bioanal Complex Matrix Samples, Changsha, Peoples R China

[6] Affiliated Hosp Xiangnan Univ, Dept Clin Pharm, Chenzhou, Peoples R China

来源：

FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷

关键词：

trimethylamine N-oxide; chronic kidney disease; gut microbiota; targeted TMAO drugs; mechanism; treatment; TRIMETHYLAMINE-N-OXIDE; FLAVIN-CONTAINING MONOOXYGENASE; L-CARNITINE; RENAL-INSUFFICIENCY; PROBIOTIC SUPPLEMENTATION; MICROBIAL-METABOLISM; SECONDARY PREVENTION; CONTRIBUTES; PROGRESSION; FMO3;

D O I：

10.3389/fphar.2022.929262

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The gut microbiota and its metabolites have become a hotspot of recent research. Trimethylamine N-oxide (TMAO) metabolized by the gut microbiota is closely related to many diseases such as cardiovascular disease, chronic kidney disease, type 2 diabetes, etc. Chronic kidney disease (CKD) is an important contributor to morbidity and mortality from non-communicable diseases. Recently, increasing focus has been put on the role of TMAO in the development and progress of chronic kidney disease. The level of TMAO in patients with chronic kidney disease is significantly increased, and a high level of TMAO deteriorates chronic kidney disease. This article describes the relationship between TMAO and chronic kidney disease and the research progress of drugs targeted TMAO, providing a reference for the development of anti-chronic kidney disease drugs targeted TMAO.

引用

页数：12

共 50 条

[31] Therapeutic Potential of Gum Arabic (Acacia senegal) in Chronic Kidney Disease Management: A Narrative Review
Alobaidi, Sami
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
[32] Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
Malyszko, Jolanta
Malyszko, Jacek S.
Matuszkiewicz-Rowinska, Joanna
EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (05) : 407 - 421
[33] Fluid overload as a therapeutic target for the preservative management of chronic kidney disease
Palmer, Biff F.
Clegg, Deborah J.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (01): : 22 - 28
[34] Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond?
Lee, Grace J.
Marks, Joanne
PEDIATRIC NEPHROLOGY, 2015, 30 (03) : 363 - 371
[35] Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond?
Grace J. Lee
Joanne Marks
Pediatric Nephrology, 2015, 30 : 363 - 371
[36] Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications
Bover, Jordi
Urena-Torres, Pablo
Luis Gorriz, Jose
Jesus Lloret, Maria
da Silva, Iara
Ruiz-Garcia, Cesar
Chang, Pamela
Rodriguez, Mariano
Ballarin, Jose
NEFROLOGIA, 2016, 36 (06): : 597 - 608
[37] Connexin 43: a New Therapeutic Target Against Chronic Kidney Disease?
Prakoura, Niki
Kavvadas, Panagiotis
Chadjichristos, Christos E.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (03) : 998 - 1009
[38] Antisense Oligonucleotide: A Potential Therapeutic Intervention for Chronic Kidney Disease
Li, Yalin
Tan, Yuqin
Zhang, Rui
Wang, Tao
Na, Ning
Zheng, Tong
Veedu, Rakesh N.
Chen, Suxiang
KIDNEY AND DIALYSIS, 2022, 2 (01): : 16 - 37
[39] Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
Zhang, Wenchao
Miikeda, Aika
Zuckerman, Jonathan
Jia, Xun
Charugundla, Sarada
Zhou, Zhiqiang
Kaczor-Urbanowicz, Karolina Elzbieta
Magyar, Clara
Guo, Fangfei
Wang, Zeneng
Pellegrini, Matteo
Hazen, Stanley L.
Nicholas, Susanne B.
Lusis, Aldons J.
Shih, Diana M.
SCIENTIFIC REPORTS, 2021, 11 (01)
[40] Consumption of Fish in Chronic Kidney Disease - A Matter of Depth
Mafra, Denise
Kemp, Julie A.
Leal, Viviane de O.
Cardozo, Ludmila
Borges, Natalia A.
Alvarenga, Livia
Teixeira, Karla T. R.
Stenvinkel, Peter
MOLECULAR NUTRITION & FOOD RESEARCH, 2023, 67 (09)

← 1 2 3 4 5 →